ArticleBMC urology2018

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors.

Liancheng Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.